Skip to content
  • Home
  • About
  • Services

    Our Services

    Operon Buildnext

    • Market Analysis
    • Product Feasibility
    • New Product Design Development
    • Product Process Engineering for Manufacturing
    • Plant Layout Detail Engineering

    Operon MarketEdge

    • Market Intelligence
    • Global Product Registration

    Operon ElevatePlus

    • Quality Management System (QMS)
    • Design History File (DHF)
    • CE Marking (EU MDR / IVDR)
    • UKCA Marking
    • US FDA (510(k), QMSR, & Registration)
    • SFDA (Saudi Arabia) Registration
    • CDSCO (India)
    • Drug–Device Combination Product Documentation
    • Veterinary Medical Devices Registration
    • BIS Certification
    • Regulatory Due Diligence for Medical Devices
    Operon BuildNext: Turnkey Project
    • Operon BuildNext
    • Market Analysis
    • Product Feasibility and DPR Services
    • New Product Design Development
    • Product Process Engineering for Manufacturing
    • Plant Layout Detail Engineering
    Operon ElevatePlus: Regulatory Services
    • Operon ElevatePlus
    • Quality Management System (QMS)
    • Design History File (DHF)
    • CE Marking (EU MDR / IVDR)
    • UKCA Marking
    • US FDA (510(k), QSMR, & Registration)
    • SFDA (Saudi Arabia) Registration
    • CDSCO (India)
    • Drug–Device Combination Product Documentation
    • Veterinary Medical Devices Registration
    • BIS Certification
    • Regulatory Due Diligence for Medical Devices
    Operon MarketEdge: Market Intelligence
    • Operon MarketEdge
    • Market Intelligence
    • Global Product Registration
  • Blogs
  • Contact
FDA 510(k) Approval

Guide to Navigating US FDA 510(k) Approval for IVDs (In Vitro Diagnostic Devices)

Read More »
Medical Device Sterilization

A Guide to Medical Device Sterilization Methods

Read More »
Post Market Clinical Follow

Post Market Clinical Follow Up

Read More »
Clinical Evaluation Report

Understanding the Clinical Evaluation Report

Read More »
SFDA regulations on MDMA

SFDA Regulations on MDMA: Significant and Non-significant Changes Explained

Read More »
UCMPMD Guidelines

UCMPMD Guidelines: How to File Self-Declaration & Marketing Expenditure Disclosure

Read More »
« Previous Page1 … Page33 Page34 Page35 Page36 Page37 … Page71 Next »
Facebook Twitter Linkedin Instagram Youtube

Quick Links

  • About
  • Careers
  • Contact

Useful Links

  • Events and Expos
  • Testimonials
  • FAQs
  • Newsletter
  • Blogs

Contact Us

+91 9403892834

enquiry@operonstrategist.com


Corporate Office

Operon Strategist, MSR Capital,
Office No. 414, Pimpri, Pune, 411018, India

OPERON

© 2026 Operon Strategist. All Rights Reserved.
Privacy Policy | Disclaimer
WhatsApp Call Us Email